Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in CVS Health Corporation (NYSE:CVS) by 10.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 235,241 shares of the pharmacy operator’s stock after buying an additional 22,836 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in CVS Health Corporation were worth $18,927,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in CVS. Bank of America Corp DE raised its holdings in CVS Health Corporation by 1.8% during the 1st quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock worth $1,759,338,000 after buying an additional 398,999 shares during the period. Macquarie Group Ltd. lifted its position in shares of CVS Health Corporation by 2.4% during the 1st quarter. Macquarie Group Ltd. now owns 9,752,261 shares of the pharmacy operator’s stock valued at $765,534,000 after acquiring an additional 225,981 shares during the period. Clearbridge Investments LLC lifted its position in shares of CVS Health Corporation by 6.8% during the 1st quarter. Clearbridge Investments LLC now owns 9,258,404 shares of the pharmacy operator’s stock valued at $726,785,000 after acquiring an additional 589,646 shares during the period. Pioneer Investment Management Inc. lifted its position in shares of CVS Health Corporation by 4.6% during the 1st quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock valued at $630,598,000 after acquiring an additional 353,621 shares during the period. Finally, Boston Partners lifted its position in shares of CVS Health Corporation by 69.1% during the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after acquiring an additional 2,638,888 shares during the period. Hedge funds and other institutional investors own 82.04% of the company’s stock.
In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.61, for a total value of $7,186,155.87. Following the completion of the sale, the executive vice president now owns 70,102 shares in the company, valued at approximately $5,580,820.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Larry J. Merlo sold 241,150 shares of the stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the transaction, the insider now directly owns 299,255 shares of the company’s stock, valued at approximately $24,859,112.85. The disclosure for this sale can be found here. Insiders sold a total of 714,125 shares of company stock valued at $58,119,381 over the last 90 days. 0.61% of the stock is currently owned by company insiders.
A number of research firms have recently commented on CVS. lowered their price target on CVS Health Corporation from $83.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, November 7th. Jefferies Group LLC decreased their price target on CVS Health Corporation from $86.00 to $76.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. restated a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and issued a $95.00 price target on shares of CVS Health Corporation in a report on Monday, October 9th. Finally, downgraded CVS Health Corporation from a “b-” rating to a “c+” rating in a research note on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. CVS Health Corporation has an average rating of “Buy” and an average price target of $85.82.
CVS Health Corporation (NYSE CVS) opened at $70.44 on Wednesday. The stock has a market capitalization of $72,408.67, a P/E ratio of 12.52, a P/E/G ratio of 1.23 and a beta of 0.86. CVS Health Corporation has a 12-month low of $66.45 and a 12-month high of $84.72. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55.
CVS Health Corporation (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a net margin of 2.77% and a return on equity of 16.96%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.64 EPS. equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were paid a $0.50 dividend. The ex-dividend date was Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.84%. CVS Health Corporation’s dividend payout ratio (DPR) is 41.32%.
WARNING: This news story was first reported by Week Herald and is the property of of Week Herald. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://weekherald.com/2017/11/15/fjarde-ap-fonden-fourth-swedish-national-pension-fund-boosts-position-in-cvs-health-corporation-cvs.html.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.